Your browser doesn't support javascript.
loading
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial.
Jin, Shuiling; Zhao, Ruihua; Zhou, Chuang; Zhong, Qian; Shi, Jianxiang; Su, Chang; Li, Qinglong; Su, Xiaoxing; Chi, Huabin; Lu, Xu; Jiang, Guozhong; Chen, Renyin; Han, Jinming; Jiang, Miao; Qiao, Shishi; Liu, Jingjing; Song, Min; Song, Lijie; Du, Yabing; Chang, Zhiwei; Wang, Meng; Dong, Meilian; Zhong, Yali; Yu, Pu; Zhang, Xiaojian; Zong, Hong.
Afiliação
  • Jin S; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhao R; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhou C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhong Q; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Shi J; BGI College & Henan Institute of Medical and Pharmaceutical Sciences in Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
  • Su C; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li Q; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Su X; Bioinformatics, Berry Oncology Co. Ltd, Fujian, China.
  • Chi H; Bioinformatics, Berry Oncology Co. Ltd, Fujian, China.
  • Lu X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Jiang G; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen R; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Han J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Jiang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Qiao S; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Liu J; Department of MR Imaging, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Song M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Song L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Du Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chang Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang M; Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Dong M; Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhong Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yu P; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang X; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zong H; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Int J Cancer ; 152(8): 1648-1658, 2023 04 15.
Article em En | MEDLINE | ID: mdl-36444498
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Neoplasias do Sistema Biliar Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China